Codex Biosciences International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.61 M
- Company Age 25 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.70 Cr
- Satisfied Charges ₹ 3.02 Cr
- Revenue Growth 8.99%
- Profit Growth 18.46%
- Ebitda 2.59%
- Net Worth 14.82%
- Total Assets 3.56%
About Codex Biosciences International
Codex Biosciences International Private Limited (CBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 February 2000 and has a history of 25 years. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Corporate was formerly known as Coion Technologies Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.61 M.
The company currently has active open charges totaling ₹3.70 Cr. The company has closed loans amounting to ₹3.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vidya Challagulla and Rajakumari Challagulla serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397AP2000PTC033511
-
Company No.
033511
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Feb 2000
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
What products or services does Codex Biosciences International Private Limited offer?
Codex Biosciences International Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Codex Biosciences International?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidya Challagulla
|
Managing Director | 09-Feb-2000 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rajakumari Challagulla
|
Director | 30-Nov-2001 | Current |
Financial Performance of Codex Biosciences International.
Codex Biosciences International Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.99% increase. The company also saw a substantial improvement in profitability, with a 18.46% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Codex Biosciences International?
Unlock access to Codex Biosciences International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cnn Properties LlpVidya Challagulla and Rajakumari Challagulla are mutual person
Charges (Loans)
₹37.00 M
₹30.20 M
Charges Breakdown by Lending Institutions
- Others : 3.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2023 | Others | ₹4.50 M | Open |
| 08 Apr 2022 | Others | ₹2.90 M | Open |
| 16 Sep 2020 | Others | ₹3.30 M | Open |
| 08 Mar 2019 | Others | ₹2.63 Cr | Open |
| 22 Nov 2011 | Others | ₹2.90 Cr | Satisfied |
How Many Employees Work at Codex Biosciences International?
Codex Biosciences International has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Codex Biosciences International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Codex Biosciences International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.